Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma

Figure 5 Hepatocellular cancer cells HepGII, Hep3B and normal fibroblast cells BJ survival curves after the cells were infected with CNHK300 at increasing MOIs. CNHK300 caused significant cytolysis in HepGII and Hep3B tumor cell lines with a MOI of 0.5 pfu/cell and 0.0002 pfu/cell. For normal fibroblast cell lines BJ in contrast, cells infected with CNHK300 showed over 50% cell viability rate at the same time points with MOI of 100 pfu/cell.